Cancer drug prices raised 50% as NPPA acts on shortage concerns

India's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follows pleas from manufacturers citing soaring platinum costs. Anti-tetanus immunoglobulin drug prices also see an increase. The National Pharmaceutical Pricing Authority invoked special powers to ensure these life-saving medicines remain accessible to the public.